Genome doubling shapes the evolution and prognosis of advanced cancers
2018 · Nature Genetics · 664 citations
https://doi.org/10.1038/s41588-018-0165-1
M
Mark T.A. Donoghue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
515
Papers
12.9K
Citations
44
h-index
80
i10-index
Mark T.A. Donoghue is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 44, co-authored 438 publications.
ORCID: 0000-0003-4538-6069Papers by this author
worksClonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
2018 · Clinical Cancer Research · 273 citations
https://doi.org/10.1158/1078-0432.ccr-18-2039
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
2020 · Cell Reports · 237 citations
https://doi.org/10.1016/j.celrep.2020.108444
Evolutionary origins of Brassicaceae specific genes in Arabidopsis thaliana
2011 · BMC Evolutionary Biology · 164 citations
https://doi.org/10.1186/1471-2148-11-47
Automated real-world data integration improves cancer outcome prediction
2024 · Nature · 123 citations
https://doi.org/10.1038/s41586-024-08167-5
Anatomic position determines oncogenic specificity in melanoma
2022 · Nature · 93 citations
https://doi.org/10.1038/s41586-022-04584-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat